Hematologist-Oncologist: Shelly Lo, MD | Loyola Medicine

Shelly Lo, MD

Shelly Lo, MD


Medical Director, Hospice

Languages Spoken

Patient Ratings
4.9 / 5 (76 Ratings)

Clinical Expertise

  • Breast Cancer
  • Chemoprevention Of Breast Cancer

About Dr. Lo

Travel, Family/Friends, Exercise

Medical Education

Medical School
SUNY Upstate Medical University College of Medicine
Albany Medical Center Hospital - Internal Medicine & Pediatrics
  • Mount Sinai Medical Center - Hematology/Oncology
  • University of Pittsburgh Medical Center - Hematology/Oncology

Board Certification

American Board of Internal Medicine Subspecialty Medical Oncology
Hospice & Palliative Medicine, American Board of Internal Medicine Subspecialty


  • Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. Yee, D; DeMichele, AM; Yau, C; Isaacs, C; Symmans, WF; Albain, KS; Chen, YY; Krings, G; Wei, S; Harada, S; Datnow, B; Fadare, O; Klein, M; Pambuccian, S; Chen, B; Adamson, K; Sams, S; Mhawech-Fauceglia, P; Magliocco, A; Feldman, M; Rendi, M; Sattar, H; Zeck, J; Ocal, IT; Tawfik, O; LeBeau, LG; Sahoo, S; Vinh, T; Chien, AJ; Forero-Torres, A; Stringer-Reasor, E; Wallace, AM; Pusztai, L; Boughey, JC; Ellis, ED; Elias, AD; Lu, J; Lang, JE; Han, HS; Clark, AS; Nanda, R; Northfelt, DW; Khan, QJ; Viscusi, RK; Euhus, DM; Edmiston, KK; Chui, SY; Kemmer, K; Park, JW; Liu, MC; Olopade, O; Leyland-Jones, B; Tripathy, D; Moulder, SL; Rugo, HS; Schwab, R; Lo, S; Helsten, T; Beckwith, H; Haugen, P; Hylton, NM; Van't Veer, LJ; Perlmutter, J; Melisko, ME; Wilson, A; Peterson, G; Asare, AL; Buxton, MB; Paoloni, M; Clennell, JL; Hirst, GL; Singhrao, R; Steeg, K; Matthews, JB; Asare, SM; Sanil, A; Berry, SM; Esserman, LJ; Berry, DA, JAMA oncology
  • Body Composition Serum Biomarkers of Inflammation and Quality of Life in Clinically Stable Women with Estrogen Receptor Positive Metastatic Breast Cancer., Sheean, P; Gomez-Perez, S; Joyce, C; Vasilopoulos, V; Bartolotta, MB; Robinson, P; Lo, S; Lomasney, L, NUTRITION AND CANCER
  • Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay Tsai, M.; Lo, S.; Audeh, W.; Qamar, R.; Budway, R.; Levine, E.; Whitworth, P.; Mavromatis, B.; Zon, R.; Oldham, D.; Untch, S.; Treece, T.; Blumencranz, L.; Soliman, H., JAMA oncology
View All ResearchShow Less
  • Brief Spiritual Well-being Screening is Non-linearly Related to Psychological Distress in Ambulatory Cancer Patients. Gerhart, J; Fitchett, G; Lillis, TA; Kuzel, TM; Lo, SS; Penedo, F; Weldon, CB; Diaz, A, PSYCHO-ONCOLOGY
  • Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Greenlee, H; Lew, DL; Hershman, DL; Newman, VA; Hansen, L; Hartman, SJ; Korner, J; Shi, Z; Sardo Molmenti, CL; Sayegh, A; Fehrenbacher, L; Lo, S; Klemp, J; Rinn, K; Robertson, JM; Unger, J; Gralow, J; Albain, K; Krouse, R; Fabian, C, Obesity (Silver Spring, Md.)
  • How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? Crew, K. D.; Albain, K. S.; Hershman, D. L.; Unger, J. M.; Lo, S. S., NPJ breast cancer
  • Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions Myrehaug, S.; Sahgal, A.; Russo, S. M.; Lo, S. S.; Rosati, L. M.; Mayr, N. A.; Lock, M.; Small, W.; Dorth, J. A.; Ellis, R. J.; Teh, B. S.; Herman, J. M., Expert Review of Anticancer Therapy
  • The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? Thomas, T. O.; Hasan, S.; Small, W., Jr; Herman, J. M.; Lock, M.; Kim, E. Y.; Mayr, N. A.; Teh, B. S.; Lo, S. S., Journal of gastrointestinal oncology
  • Differentially expressed genes and pathways induced by organophosphates in human neuroblastoma cells Li, T.; Zhao, H.; Hung, G. C.; Han, J.; Tsai, S.; Li, B.; Zhang, J.; Puri, R. K.; Lo, S. C., Experimental biology and medicine (Maywood, N.J.)
  • Extrapulmonary small cell carcinoma of the anal canal: a case report and review of the literature Eberhardt, J. M.; Brown, K.; Lo, S.; Nagda, S.; Yong, S., Case reports in medicine
  • Impact of Multigene Assays in Early Stage Breast Cancer Lo, S. S.; Albain, K. S., Oncologist
  • Roadmap for harmonization of clinical laboratory measurement procedures Greg Miller, W.; Myers, G. L.; Lou Gantzer, M.; Kahn, S. E.; Schonbrunner, E. R.; Thienpont, L. M.; Bunk, D. M.; Christenson, R. H.; Eckfeldt, J. H.; Lo, S. F.; Nubling, C. M.; Sturgeon, C. M., Clinical chemistry
  • A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas Lo, S. S.; Khorana, A. A.; Javle, M.; Simon, S.; Kiefer, G.; Rajasenan, K.; Wang, H.; Hantel, A.; Shayne, M.; Hwang, J.; Schmotzer, A.; Ramanathan, R. K., ONCOLOGY
  • Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien, P.; Lo, S.; Albain, K. S.; Robinson, P.; Rajan, P.; Strack, P. R.; Golde, T. E.; Miele, L.; Foreman, K. E., Anticancer Research
  • Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. Lo, S. S.; Mumby, P. B.; Norton, J.; Rychlik, K.; Smerage, J.; Kash, J.; Chew, H. K.; Gaynor, E. R.; Hayes, D. F.; Epstein, A.; Albain, K. S., Journal of Clinical Oncology
  • Residual disease after neoadjuvant chemotherapy for breast cancer Morris, G. J.; Robinson, P. A.; Lo, S.; Samuel, T. A.; Sheikh, A. A.; Jordan, W. E., 3rd; Thomas, L. C.; Kiel, K.; Peters, C. A., Seminars in oncology
  • Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings Lo, S. S.; Pritchard, K. I.; Robinson, P.; Albain, K. S., Cancer treatment and research
  • Estimating the changes in energy flux that characterize the rise in obesity prevalence. Swinburn, B. A.; Sacks, G.; Lo, S. K.; Westerterp, K. R.; Rush, E. C.; Rosenbaum, M.; Luke, A.; Schoeller, D. A.; DeLany, J. P.; Butte, N. F.; Ravussin, E., American Journal of Clinical Nutrition
  • Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. Nagda, S. N.; Mohideen, N.; Lo, S. S.; Khan, U.; Dillehay, G.; Wagner, R.; Campbell, S.; Flanigan, R. C., International journal of radiation oncology, biology, physics
  • Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Albuquerque, K. V.; Singla, R.; Potkul, R. K.; Smith, D. M.; Creech, S.; Lo, S.; Emami, B., Gynecologic oncology
  • Neoadjuvant therapy: an emerging concept in oncology Tanvetyanon, T.; Clark, J. I.; Campbell, S. C.; Lo, S. S., Southern medical journal
  • Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production Yip, K. H.; Zheng, M. H.; Steer, J. H.; Giardina, T. M.; Han, R.; Lo, S. Z.; Bakker, A. J.; Cassady, A. I.; Joyce, D. A.; Xu, J., Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • Unusual thoracic problems in patients with malignancies: case 1. Neuroblastoma presenting with intracardiac tumor thrombus. Nagda, S. N.; Lo, S. S.; Melian, E.; Manera, R.; Emami, B., Journal of Clinical Oncology
  • Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs) Lo, S. S.; Vogel, V. G., Best practice & research.Clinical endocrinology & metabolism
  • Multimodality treatment in a case of primary cardiac lymphoma Lo, S. S.; Yeager, A. M.; Peel, R. L.; Katz, W. E.; Ramanathan, R. K., Clinical lymphoma